Clinical Trials in Los Angeles

Showing 1141-1160 of 16,901 trials

N-Acetyl-L-Leucine for Ataxia-Telangiectasia (A-T)

NCT03759678

This is a multinational, multicenter, open-label, rater-blinded prospective Phase II study which will assess the safety and efficacy of N-Acetyl-L-Leucine (IB1001) for the treatment of Ataxia-Telangiectasia (A-T). There are two phases to this study: the Parent Study, and the Extension Phase. The Parent Study evaluates the safety and efficacy of N-Acetyl-L-Leucine (IB1001) for the symptomatic treatment of A-T. The Extension Phase evaluates the long-term safety and efficacy of IB1001 for the neuroprotective, disease-modifying treatment of A-T.

Ataxia Telangiectasia

IntraBio Inc17 participantsStarted Jan 2020

Los Angeles, California, United States • Giessen, Germany • Madrid, Spain, Spain +1 more locations

Active Not RecruitingPhase 3< 1 mile

A Study to Evaluate the Efficacy and Safety of Subcutaneous Tildrakizumab in Subjects With Moderate to Severe Genital Psoriasis.

NCT06611163

Phase 3 study to evaluate the efficacy and safety of subcutaneous tildrakizumab in subjects with moderate to severe genital psoriasis.

Moderate to Severe Genital Psoriasis

Sun Pharmaceutical Industries Limited206 participantsStarted Mar 2025

Anaheim, California, United States • Encinitas, California, United States • Encino, California, United States +53 more locations

N-Acetyl-L-Leucine for Ataxia-Telangiectasia (A-T)

A Study to Evaluate the Efficacy and Safety of Subcutaneous Tildrakizumab in Subjects With Moderate to Severe Genital Psoriasis.

Find Trials by Condition in Los Angeles

A Study to Assess Adverse Events and Change in Disease Activity of Intravenously (IV) Infused ABBV-324 in Adult Participants With Hepatocellular Cancer (HCC) or Squamous-Cell Non-Small Cell Lung Cancer (LUSC)

A Study With Self-administered Rocatinlimab in Adolescent and Adult Participants With Moderate-to-severe Atopic Dermatitis

Phase 3 Study of Teclistamab in Combination With Lenalidomide and Teclistamab Alone Versus Lenalidomide Alone in Participants With Newly Diagnosed Multiple Myeloma as Maintenance Therapy Following Autologous Stem Cell Transplantation

A Phase 3 Study of Barzolvolimab in Participants With Chronic Spontaneous Urticaria

Multi-Center Study of Panosyl-Isomaltooligosaccharides Adjunctive to PPI Therapy to Treat GERD

A Phase 3 Study of Barzolvolimab in Participants With Chronic Spontaneous Urticaria (CSU)

Examining the Role of Female Endogenous Sex Hormones in Eccentric Exercise

Study to Describe the Safety, Tolerability, Immunogenicity, and Efficacy of RNA Vaccine Candidates Against COVID-19 in Healthy Individuals

Letrozole With or Without Paclitaxel and Carboplatin in Treating Patients With Stage II-IV Ovarian, Fallopian Tube, or Primary Peritoneal Cancer

JUST BREATHE, Breathing Life Into Innovative Therapies for ARDS (Master Record)

Study to Evaluate Safety, Tolerability and Pharmacokinetics of IDB-011

Double-blind, Placebo-controlled Study in Adults With Major Depressive Disorder

Dexmedotomidine for Acute Pain Control in Patients With Multiple Rib FracturesRandomized Controlled Trial

Use of a Screening Tool to Describe HIV-Related Cancer Burden and Patient Characteristics in the AMC

Long Term Follow-up for RGX-202

Evaluation of Safety and Efficacy of Micro-coring Device for Treatment of Facial Wrinkles and Skin Laxity

A Long-term, Post-marketing Safety Study of Palynziq in Patients With PKU (PALace)

A Study to Learn About the Effects of Two Study Medicines (Maplirpacept [PF-07901801] And Glofitamab) When Given Together In People With Relapsed Or Refractory Diffuse Large B Cell Lymphoma.